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Abstract
Background: Gastrointestinal (GI) tract cancer is one of the common causes of the mortality due to cancer in
most developing countries such as Iran. The digestive tract is the major organ involved in the cancer. The northern
part of the country, surrounded the Caspian Sea coast, is well known and the region with highest regional
incidence of the GI tract cancer. In this paper our aim is to study the most common risk factors affecting the
survival of the patients suffering from GI tract cancer using parametric models with frailty.
Methods: This research was a prospective study. Information of 484 cases with GI cancer was collected from Babol
Cancer Registration Center during 1990-1991. The risk factors we studied are age, sex, family history of cancer,
marital status, smoking status, occupation, race, medication status, education, residence (urban, rural), type of
cancer, migration status (indigenous, non-native). The studied cases were followed up until 2006 for 15 years.
Hazard ratio was used to interpret the death risk. The effect of the factors in the study on the patients survival are
studied under a family of parametric models including Weibull, Exponential, Log-normal, and the Log-logistic
model. The models are fitted using with and without frailty. The Akaike information criterion (AIC) was considered
to compare between competing models.
Results: Out of 484 patients in the study, 321 (66.3%) were males and 163 (33.7%) were females. The average age
of the patient at the time of the diagnosis was 59 yr and 55 yr for the males and females respectively.
Furthermore, 359 (74.2%) patients suffered from esophageal, 110 (22.7%) patients recognized with gastric, and 15
(3.1%) patients with colon cancer. Survival rates after 1, 3, and 5 years of the diagnosis were 24%, 16%, and 15%,
respectively. We found that the family history of the cancer is a significant factor on the death risk under all
statistical models in the study. The comparison of AIC using the Cox and parametric models showed that the
overall fitting was improved under parametric models (with and without frailty). Among parametric models, we
found better performance for the log-logistic model with gamma frailty than the others. Using this model, gender
and the family history of the cancer were found as significant predictors.
Conclusions: Results suggested that the early preventative care for patients with family history of the cancer may
decrease the risk of the death in the patients with GI cancer. The gender appeared to be an important factor as
well so that men experiencing lower risk of death than the women in the study. Since the proportionality
assumption of the Cox model was not held (p = 0.0014), the Cox regression model was not an appropriate choice
for analysing our data.
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Cancer is known as one of the major causes leading to
many disorders, death, and disabilities worldwide [1,2].
Cancer has affected increasingly the human population
during the past decades so that considerable amount of
health care resources have been allocated to diminish its
side effects [3]. It is predicted to become the leading
cause of death in many developed and developing coun-
tries such as Iran [1,4].
Esophageal, Stomach, and Colorectal cancers are three
most common types of cancer among Iranian popula-
tion [5]. The Northern part, located on the Caspian
coast has been reported as the main area of the county
dominated by Gastrointestinal (GI) Malignancies tract
cancer [6,7]. Out of 70.4 million of the country’s popula-
tion, almost 50,000 new cases of cancer are reported
each year. In more than 38% cases, the GI tract is par-
tially or completely affected.
Stomach, esophageal, and colon cancer are three most
common types of cancers reported among males. For
females, the breast cancer should be added to this list
[8,9]. Cancer is the third most common cause of death
in Iran. This accounts for 14% of the total mortality of
which the GI cancer accounts for approximately half
(44.4%) of all cancers related deaths [10,11]. Unfortu-
nately, the GI cancer in Iran is diagnosed when the dis-
ease is in its developed phase and hence the patience
the available therapies treatment are less effective to
cure the patience [1,11]. Practically, the early diagnosis
of the GI tract cancer gives more chance to the patients
to recover from the discomfort.
Survival data are often modeled using the Cox propor-
tional hazards model which estimates the covariate
effects as the log hazard ratios. This model is free of
estimating the baseline hazards for the model. However,
since the hazard function is directly related to the time
course of the disease, its behavior may be of medical
interest. The baseline hazard rate can help us to under-
stand the common history of the disease respect to the
hazard rate changing over time [12,13]. Cox’s semi-para-
metric regression model [14]i sf r e q u e n t l yu s e dt oa n a -
lyse the survival data. Alternatively the fully parametric
models such as Weibull, Log-Logistic and Log-Normal
models can be used [15,16]. They can offer a gain that
may not be obtained under Cox’s model. Efron [17] and
Oakes [18] showed asymptotically that under certain cir-
cumstances, parametric models can lead to more effi-
cient estimates of the parameter.
In survival analysis, to model the data in which the
mortality reaches a peak and then starts to decline, a
model with a non-monotonic (hump-shaped) failure rate
c a nb eu s e d .T h i si st h ec a s ew i t ho u rd a t aw eu s ei n
this paper. In order to capture efficiently this property
of data, the Log-logistic and Log-normal model are
often used [13]. However, If the issue of outliers is not
major, the Log-logistic model can be used to approxi-
mate the Log-normal model. Moreover, for censored
data, the Log-logistic model has a simple hazard form
and survival function [12,13]. For these reasons, we use
the Log-logistic function in this paper for analyzing our
data.
The aforementioned pattern for hazard function was
the case in our study. Hazard function increased slowly
until after a while started to decline. Because of this pat-
tern in our data Cox, Weibull, and Exponential models
are not appropriate ones and as was said in above Log
logistic model seems better as results of our findings
verified the issue.
It is assumed that for the unique covariate inputs, the
survival function under the Cox proportional hazards
and parametric models is the same for subjects. How-
ever, the data may present extra-variation due to the
unobserved factors. In this study, we collected data on
all possible factors we thought might influence the
patient’s survival.
A model becoming increasingly popular for modeling
the multi-level individual survival times is frailty model.
A frailty is an unobserved random effect shared by sub-
jects within a sub-group. Frailty models are also used to
capture the overdispersion in univariate survival studies.
In this paper, the frailty refers to the effect of the unob-
served factors on the subject’s survival. Ignoring frailty
may lead to the biased survival estimates. The overdis-
persion is modeled using a latent multiplicative effect
on the hazard, or frailty. A gamma or inverse-Gaussian
distribution is commonly used to model the frailty
[12,19-22]. Thus, the hazard of a population is inter-
preted as the mean of individual hazards among the sur-
vivors. Frail individual with notable values of frailty will
tend to die sooner [19]. The frailty (random effect) can
be integrated out (in closed form or by numerical or
stochastically integration, depending on the frailty distri-
bution) to get a likelihood function not depending on
unobserved quantities [19].
By the expectation is conditional on being at risk at
time point t, it mention averaging over a subset of the
original population. Therefore, relative weights for
hazards with high frailty become smaller as time goes
by, corresponding to high mortality. An important
implication is that studies of human aging based on
cohort mortality data may be systematically biased or
based on erroneous functional forms [19]. The aim of
the this paper is to investigate the factors influencing
the survival of the patients with GI tract cancer using
parametric models with frailty. We also compare our
results with that of achieved under the Cox model.
Ghadimi et al. BMC Gastroenterology 2011, 11:104
http://www.biomedcentral.com/1471-230X/11/104
Page 2 of 9Methods
This survey was a prospective study. The total number
of 484 patients with developed GI tract cancer registered
at the Babol Cancer Registration Center during 1990-
1991. They then followed up for 15 years until 2006.
The socio-demographic and clinical data obtained using
questionnaire and the patients’ clinical records. Written
informed consent from patients was obtained prior to
entering the study. Patients completed a questionnaire
that assessed satisfaction with the informed consent pro-
cedure. Also to maintain patient privacy, all records
were coded with a unique project identifier prior to
transmission to the data collection. The study was con-
firmed by the Ethics Committee of Tehran University of
Medical Sciences. The factors we consider in our study
are age at diagnosis, gender, place of residence, pro-
vince, type of cancer, method of cancer detection, family
history of cancer, education, job, marital status, cigarette
smoking, ethnicity, migration status, drug use.
A multivariate parametric regression model (with and
without frailty) was developed to analyse the prognostic
factors related to the longevity of patients. To compare
the different parametric models and their efficiency the
Akaike Information Criterion (AIC) [23], Cox-Snell, and
deviance residual plots were used. The AIC was consid-
ered to assess the general goodness of fit of the statisti-
c a lm o d e l s .T h el o w e rv a l u eo ft h eA I C ,t h eb e t t e r
model to fit the data. Hazard rate (HR) [12,24] was used
to interpret the death risk of the parametric models. For
the statistical analysis, the statistical software SAS 9.1
and STATA 8.0 were used. The values less than 0.05 for
probability, p ≤ 0.05, was defined as the level of our sta-
tistical significance.
Results
Out of 484 initial patients with developed GI cancer,
321 (66.3%) were men and 163 (33.7%) women. The
mean ± standard deviation of age at diagnosis was 58.26
± 10.9 years and the median survival time was found 9.1
months. The estimated survival rates in 1, 3, and 5 years
after diagnosis were 0.24, 0.16, and 0.15 respectively.
The type of cancer in these patients was as follows: eso-
phageal (74.2%), stomach (22.7%) and colon (3.1%)
(Table 1). During the following up, the total number of
426 (88.0%) deaths were observed (non-censored obser-
vations) and 88 (12.0%) patients survived or exact details
of their survival status were not available (Loss to follow
up)(right censored observations).
According to the fact that the proportionality assump-
tion of Cox model was not met in our data (p =
0.0014), using Cox regression was not suitable, even
adding frailty term (with gamma and inverse-Gaussian)
in to Cox model, proportionality assumption was ever
violated and there was no remedy in the violation of the
PH assumption. Thus Cox model was omitted from
study.
The Kaplan-Meier estimates of the survival functions
for the gender and the family history of the cancer are
given in the Figure 1.
Figures 2, 3 plots the Cox-Snell and deviance residuals
under the parametric models; log-normal, log-logistic,
and Weibull model. In overall, the plots show smaller
residuals using parametric models and therefore we may
conclude they have better performance than the Cox
model. Furthermore, the parsimonious of the Cox-Snell
Table 1 Characteristics of patients with Gastrointestinal
tarct cancer diagnosis
Characteristic n (%)
Gender
Male 321 (66.3)
Female 163 (33.7)
Place of residence
Rural 256 (52.9)
Urban 228 (47.1)
Province
Mazandaran 288 (59.5)
Golestan 196 (40.5)
Type of cancer
Esophageal 359 (74.2)
Stomach 110 (22.7)
Colorectal 15 (3.1)
Method of cancer detection
Clinical diagnosis 35 (7.2)
Direct endoscopy and biopsy 39 (8.1)
Conventional chest x-ray 410 (84.7)
Family history of cancer 142 (29.3)
Education
Literate 52 (10.7)
Illiterate 432 (89.3)
Job
Farmer 252 (52.1)
Employee 7 (1.4)
Others 225 (46.5)
Marital status
Married 459 (94.8)
Single 25 (5.2)
Cigarette smoking 215 (44.4)
Ethnicity
Aryan 327 (67.6)
Gilak 12 (2.5)
Torkaman 100 (20.7)
Others 45 (9.2)
Migration status
Native 430 (88.8)
Non-native 54 (11.2)
Drug use 119 (24.6)
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with gamma frailty to the 45 degrees line in Figure 3
confirms these models provide better fitting to our data.
It can be also seen that the log-logistic model has better
performance over the log-normal model. The weak per-
formance of the Weibull model which assumes the pro-
portional hazards can be due to the violation
assumption of the proportional hazards.
The similar conclusion can be obtained by using AIC.
The AIC of each model in the study is given in Table 2.
The best scores are achieved under the log-logistic
model. The Weibull model is the next best model fol-
lowed by the log-normal. Table 2 also suggests the log-
logistic with gamma frailty as the most efficient model
for our data.
Table 3 reports the detailed results of the multivariate
analysis for the parametric models with and without
frailty based on the HR for each variable. Results of the
multivariate analysis show that the family history of the
cancer appears a significant factor in all fitted models.
This implies that patients with the family history of the
cancer are less survived than others.
Gender is significant under the log-normal and log-
logistic with gamma frailty model but not significant
factor under other models. This indicates that the level
of the death risk due to GI cancer was reduced signifi-
cantly for the women in the study during the following
up period.
None of the parametric models suggests age, resi-
dence, province, type of cancer, methods of cancer diag-
nosis, educational level, occupation, smoking, ethnicity,
migration status and drug use as a significant prognostic
factors.
Discussion
GI tract cancer is one of the most common types of
cancer in Iran [10]. The cancer is a particularly devastat-
ing form of cancer with a relatively low survival rate,
and people generally will not live a long time after diag-
nosis. Several factors known in various studies as influ-
encing prognosis factors and have been introduced
[25-33].
In the literature, there are many studies on the field of
cancer, but researchers tend to examine the effects of
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Figure 1 Survival curve of GI tract cancer patients using Kaplan-Meier method. (a), (b) Kaplan-Meier estimates of the survival curves for GI
tract cancer data separated by family history of cancer and gender, respectively. (c) Kaplan-Meier overall survival curves.
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model instead of parametric ones. A systematic study on
Cancer Journals shows that only in 5% of studies of can-
cer in which Cox regression model is used the assump-
tions of the model have been investigated [34]. If
presumptions are not met, results of Cox model are ser-
iously under question. As an alternative, parametric
models such as log-normal, log logistic, Weibull, and
exponential can be employed. The only assumption of
parametric models is that the variable time follows a
specific distribution [13,24].
In this paper we aimed to study the possible relation-
ship between the survival of the patients with GI tract
cancer and several most common prognosis factors such
as age at diagnosis, gender, place of residence, province,
type of cancer, method of cancer detection, family his-
tory of cancer, education, job, marital status, cigarette
smoking, ethnicity, migration status, drug use.
We found gender and the family history of the cancer
significant prognostic factor. This supports the past stu-
dies reporting better survival for women with developed
GI tract cancer [1,35-37] and the family history of the
disease as a significant factor [38,39].
Statistical assessment using AIC of the studied models
showed that the log-logistic model with gamma frailty
will describe our data better.
Due to their better performance, our intension is to
use parametric models. However, the efficiency of the
parametric models is greatly affected by the volume of
the censored observations. For having sensible results, it
is recommended that the percentage of the censored
data should not be more than 50%[40]. This condition
is satisfied with our data as they consist of 15% censored
observations.
Nardi et al. [40] compared the performance of the
Cox model and some parametric models. They used
normal-deviate residuals [41] to evaluate the assump-
tions of parametric models. They also studied Weibull
model based on the estimated variation of the parameter
rate criteria, and concluded that the Weibull was the
superior model. In our study, we found the log-logistic
model to have better performance than the other mod-
els in the study.
By a simulation study, HRbe et al. [42] compared the
Cox regression model and the accelerated failure time
(AFT) models. They used the proposed method by Stute
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Figure 2 Deviance residuals to evaluate model fit of parametric models. In this plot, the deviance residual is large for short survival times
and then decreases with time. This pattern suggests that the log normal and log logistic models with gamma frailty are better than other both
models (The log logistic model has the lowest mean deviance residual with respect to other models).
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sored data. Their results showed that whatever the pro-
portional hazards assumption is violated or not, the log
logistic, log-normal, and the Stute models are more effi-
cient than the Cox model.
Bradburn et al. [44] evaluated the adequacy of some
parametric models and the Cox proportional hazards
model using model’s residuals and the AIC. They found
that the generalized gamma model and parametric mod-
els achieved both a higher log-likelihood and a lower
AIC.
For the Cox and parametric models, the hazard func-
tion may depend on the unknown or latent factors
which can lead to the biased estimates of the regression
coefficients [19,45]. To overcome this issue we used the
frailty models. In fact these models are used to explain
the random variation of the survival function that may
exist due to unknown risk factors such as genetic factors
and other environmental factors [19,22,45-47].
Random effects models are known as the frailty mod-
els in the survival analysis. These models, widely studied
in the 1990’s, are relatively new in the survival field and
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Figure 3 Cox-Snell residuals obtained from fitting various survival models with gamma frailty to the GI tract cancer data. The panels
indicate the Cox-Snell residuals (together with their cumulative hazard function) obtained from fitting different parametric models to the same
data via maximum likelihood estimation.
Table 2 Overview of the Akaike Information Criterion
Scores
AIC Rank
Without Heterogeneity
Exponential 2127.24 4
Weibull 1918.18 3
Log-normal 1800.44 2
Log-logistic 1786.94 1
AIC Rank
Gamma Heterogeneity
Exponential 1780.94 4
Weibull 1739.86 2
Log-normal 1746.16 3
Log-logistic 1717.84 1
AIC Rank
Inverse Gaussian Heterogeneity
Exponential 1851.98 4
Weibull 1851.58 2
Log-normal 1759.78 3
Log-logistic 1725.02 1
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problems in estimating the parameters of frailty models
made to be used less compared to the Cox model.
Using frailty to model the extra-variation in univariate
lifetime data goes back to the work of Vaupel et al.
[48]. Henderson and Oman [49] in a theoretical method
revealed that in case of non-use of frailty model when
there is frailty effect bias may occur in the estimates of
regression coefficients. Schumacher et al. [50] showed
that ignoring an important factor can lead to lower
estimations of the relative risk by the fitted models.
Keiding et al. [51] showed how removing one of the
two explanatory variables might increase the variance of
the hazard function and biased estimation of other coef-
ficients in the fitted model. They suggested using AFT
models to handle the effect of unobserved variables.
According to our findings, log logistic model with
gamma frailty is more suitable statistical model in survi-
val analysis in patients with GI cancers rather than
other parametric models.
Table 3 Multivariate model of parametric models with and without frailty
variables Exponential Weibull Log-normal Log-logistic
HR (P-value) HR (P-value) HR (P-value) HR (P-value)
without
frailty
Gamma
frailty
Inv-
Gussian
frailty
without
frailty
Gamma
frailty
Inv-
Gussian
frailty
without
frailty
Gamma
frailty
Inv-
Gussian
frailty
without
frailty
Gamma
frailty
Inv-
Gussian
frailty
Age(years) 1.005
(0.296)
1.01
(0.291)
1.01
(0.244)
1.01
(0.316)
1.01
(0.172)
1.01
(0.253)
1.01
(0.252)
1.01
(0.268)
1.01
(0.248)
1.01
(0.269)
1.01
(0.206)
1.01
(0.188)
Gender 1.12
(0.459)
1.32
(0.232)
1.25
(0.324)
1.11
(0.469)
1.47
(0.059)
1.22
(0.348)
1.37
(0.152)
1.64
(0.011)*
1.61
(0.022)*
1.28
(0.245)
1.45
(0.041)*
1.47
(0.042)*
Place of
residence
1.15
(0.199)
0.99
(0.945)
1.07
(0.668)
1.07
(0.514)
0.95
(0.714)
1.06
(0.697)
1.02
(0.901)
0.96
(0.768)
0.98
(0.891)
0.99
(0.992)
0.92
(0.492)
0.93
(0.568)
Province 0.76
(0.069)
0.96
(0.814)
0.77
(0.132)
0.79
(0.050)*
1.09
(0.611)
0.79
(0.161)
0.87
(0.412)
1.06
(0.709)
1.01
(0.989)
0.93
(0.669)
1.12
(0.393)
1.12
(0.453)
Type of cancer 0.87
(0.209)
0.95
(0.797)
0.88
(0.420)
0.9
(0.328)
0.99
(0.968)
0.88
(0.432)
0.93
(0.623)
1.05
(0.728)
1.02
(0.921)
0.94
(0.715)
1.03
(0.835)
1.02
(0.901)
Family history of
cancer
1.85(<
0.001) *
1.69
(0.004)*
1.92 (<
0.001)*
1.54 (<
0.001)*
1.49
(0.009)*
1.82 (<
0.001)*
1.82
(0.001)*
1.47
(0.013)*
1.56
(0.007)*
1.72
(0.001)*
1.39
(0.016)*
1.43
(0.013)*
Education 0.6
(0.004)*
0.63
(0.114)
0.6
(0.054)
0.69
(0.036)*
0.74
(0.213)
0.62
(0.059)
0.62
(0.071)
0.73
(0.201)
0.7
(0.150)
0.6
(0.060)
0.79
(0.307)
0.77
(0.270)
Marital status 1.61
(0.063)
1.64
(0.224)
1.75
(0.139)
1.45
(0.156)
1.49
(0.222)
1.69
(0.150)
1.67
(0.180)
1.35
(0.379)
1.47
(0.272)
1.67
(0.177)
1.31
(0.361)
1.39
(0.305)
Cigarette
smoking
1.35
(0.014)*
0.99
(0.989)
1.23
(0.263)
1.2
(0.109)
0.9
(0.533)
1.2
(0.289)
1.06
(0.718)
0.84
(0.306)
0.9
(0.528)
1.03
(0.871)
0.85
(0.298)
0.87
(0.363)
Migration status 1.40
(0.047)*
1.35
(0.266)
1.43
(0.154)
1.23
(0.194)
1.37
(0.194)
1.39
(0.170)
1.45
(0.157)
1.35
(0.191)
1.41
(0.157)
1.35
(0.227)
1.28
(0.267)
1.3
(0.238)
Drug use 0.95
(0.727)
1.11
(0.624)
1.01
(0.958)
0.97
(0.837)
1.07
(0.674)
1.01
(0.944)
1.06
(0.758)
1.11
(0.561)
1.1
(0.614)
1.11
(0.598)
1.09
(0.618)
1.09
(0.637)
Method of cancer
detection (Direct
endoscopy and
biopsy)
0.64
(0.023)*
0.89
(0.751)
0.73
(0.292)
0.76
(0.259)
1.11
(0.814)
0.76
(0.319)
0.84
(0.573)
1.11
(0.712)
1.06
(0.839)
0.85
(0.613)
1.07
(0.790)
1.08
(0.775)
Method of cancer
detection (Clinical
diagnosis)
0.39 (<
0.001)*
0.57
(0.142)
0.44
(0.011)*
0.51
(0.003)*
0.70
(0.495)
0.46
(0.013)*
0.56
(0.071)
0.95
(0.878)
0.84
(0.586)
0.52
(0.059)
0.93
(0.795)
0.88
(0.688)
Job (Employee) 1.06
(0.895)
0.85
(0.829)
0.95
(0.937)
0.98
(0.972)
0.69
(0.758)
0.93
(0.917)
1.13
(0.856)
1.89
(0.445)
1.71
(0.494)
0.85
(0.814)
0.84
(0.773)
0.83
(0.772)
Job (Others) 1.01
(0.926)
0.98
(0.918)
1.01
(0.944)
0.99
(0.996)
0.99
(1.00)
1.01
(0.972)
1.04
(0.832)
1.08
(0.638)
1.09
(0.618)
0.97
(0.873)
0.99
(0.936)
0.99
(0.967)
Ethnicity (Gilak) 1.35
(0.329)
0.53
(0.211)
0.87
(0.783)
1.08
(0.806)
0.22
(0.041)*
0.85
(0.745)
0.62
(0.351)
0.39
(0.027)*
0.42
(0.061)
0.58
(0.224)
0.43
(0.020)*
0.42
(0.023)*
Ethnicity
(Torkaman)
1.33
(0.089)
1.30
(0.327)
1.35
(0.255)
1.23
(0.202)
1.34
(0.434)
1.32
(0.255)
1.24
(0.414)
1.04
(0.878)
1.04
(0.881)
1.34
(0.231)
1.23
(0.293)
1.21
(0.351)
Ethnicity (Others) 1.18
(0.377)
1.39
(0.267)
1.21
(0.490)
1.12
(0.517)
1.79
(0.160)
1.21
(0.476)
1.23
(0.469)
1.26
(0.344)
1.21
(0.465)
1.39
(0.229)
1.52
(0.062)
1.48
(0.092)
* Significant at 0.05 level
HR, Hazard rate
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Our study showed that the gender and the family his-
tory of the cancer were two factors that can significantly
affect the lifetime of the patients with GI tract cancer.
According to our findings the early recognition of
family history of cancer and, in consequence, awareness
of family members to consider the possibility of family
screening may result in a decrease in death rate due to
GI tract cancer.
Furthermore, we found that the death risk of the GI
tract cancer for the men was significantly lower than the
women. We also recommended to use the log-logistic
with gamma frailty model, to evaluate the effects of the
prognostic factors on the developing the GI tract cancer.
Limitation
One of the limitations of this study was the lack of an
efficient recording medical system in the Babool Cancer
Registeration Center. Currently there is no any informa-
tion available for some clinical factors such as the type
of esophageal cancer (adenocarcinoma, squamous) and
the stage of the disease.
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